Dyne Therapeutics Overview
Dyne Therapeutics Target Price
Analysts' 12-month price predictions for DYN.
Share Price
$8.76
Average Target Price
$34.00
288.1% upside
288.1% upside1 analysts in the last 4 months
High: $34 | Low: $34
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-02 | OppenheimerAndreas Argyrides | $34 | 288.1% upside |  |
| 2025-02-28 | UBS | $48 | 447.9% upside | |
| 2025-02-28 | H.C. Wainwright | $46 | 425.1% upside | |
| 2024-08-14 | Morgan StanleyMichael Ulz | $52 | 493.6% upside | |
| 2024-08-13 | Piper SandlerEdward Tenthoff | $53 | 505% upside | |
| 2024-06-24 | JefferiesEun Yang | $42 | 379.5% upside | |
| 2024-06-17 | OppenheimerFrancois Brisebois | $55 | 527.9% upside | |
| 2024-05-21 | Chardan CapitalKeay Nakae | $42 | 379.5% upside | |
| 2024-05-20 | H.C. WainwrightAndrew Fein | $48 | 447.9% upside | |
| 2024-05-20 | Stifel NicolausPaul Matteis | $41 | 368% upside | |
| 2024-04-30 | Morgan StanleyMichael Ulz | $40 | 356.6% upside | |
| 2022-11-29 | J.P. Morgan | $18 | 105.5% upside | |
| 2022-09-06 | Piper SandlerEdward Tenthoff | $23 | 162.6% upside | |
| 2022-07-12 | Piper SandlerEdward Tenthoff | $17 | 94.1% upside | |